Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:53 PM
Ignite Modification Date:
2025-12-24 @ 3:53 PM
NCT ID:
NCT06701292
Eligibility Criteria:
Inclusion Criteria:
* Symptomatic paroxysmal AF refractory to at least one Class I or Class III antiarrhythmic medication, intolerance to antiarrhythmic medications, or a preference to not trial antiarrhythmic medications
* A minimum of one documented AF episode via 12-lead ECG, Holter monitor, or loop recorder
* Capability to provide informed consent
Exclusion Criteria:
* Persistent or permanent AF
* Prior history of catheter or surgical ablation for AF or left atrial ablation for atypical flutter
* Reversible causes of AF
* Congenital heart disease
* Significant valve disease (moderate or severe mitral/aortic stenosis or regurgitation)
* Pregnancy
* Known presence of intracardiac thrombus
* Systemic oral anticoagulation therapy contraindicated, including a history of heparin-induced thrombocytopenia
* Broad vortex-like connections and no clear PVMS to be targeted
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06701292
Study Brief:
Protocol Section:
NCT06701292